Megola, Inc. (OTCPK:MGON) entered into definitive agreement to acquire License of Intellectual Property, Product Lines, Manufacturing & Other Assets of Medesol Global Inc. for $0.25 million on September 20, 2022. Medesol Global Inc receives 25,000 Restricted PFD D shares with a stated value of $10 per share. Megola's BOD will also determine future royalties to Medesol Global per specific product sales generated.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0069 USD | 0.00% | -9.21% | +187.50% |
1st Jan change | Capi. | |
---|---|---|
+187.50% | 2.01M | |
+13.03% | 26.04B | |
-5.67% | 16.74B | |
-17.56% | 6.44B | |
+9.04% | 6.16B | |
-0.78% | 3.2B | |
-2.83% | 2.3B | |
-9.88% | 1.97B | |
+27.31% | 955M | |
-0.44% | 646M |
- Stock Market
- Equities
- MGON Stock
- News Megola, Inc.
- Megola, Inc. entered into definitive agreement to acquire License of Intellectual Property, Product Lines, Manufacturing & Other Assets of Medesol Global Inc. for $0.25 million.